{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:54:41Z","timestamp":1785578081510,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrep.2018.05.007","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T07:13:16Z","timestamp":1527837196000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2627-8524","authenticated-orcid":false,"given":"Youki","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Dansako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Nishitsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Hishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitada","family":"Shimotohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2018.05.007_bib1","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/jm010026g","article-title":"Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes","volume":"44","author":"Kim","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrep.2018.05.007_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.parint.2011.04.001","article-title":"Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol","volume":"60","author":"Sato","year":"2011","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.bbrep.2018.05.007_bib3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.parint.2011.08.017","article-title":"Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) and its carboxylic acid derivatives","volume":"60","author":"Sato","year":"2011","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.bbrep.2018.05.007_bib4","doi-asserted-by":"crossref","first-page":"e72519","DOI":"10.1371\/journal.pone.0072519","article-title":"New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication","volume":"8","author":"Ueda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2018.05.007_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrep.2018.05.007_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virusres.2017.03.015","article-title":"Evaluation of preclinical antimalarial drugs, which can overcome direct-acting antivirals-resistant hepatitis C viruses, using the viral reporter assay systems","volume":"235","author":"Ueda","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrep.2018.05.007_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.virusres.2014.10.010","article-title":"Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable omf expressing a foreign gene","volume":"195","author":"Ishikawa","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrep.2018.05.007_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7883\/yoken.67.209","article-title":"Development of a novel dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs","volume":"67","author":"Kato","year":"2014","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.bbrep.2018.05.007_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1348-0421.12219","article-title":"Establishment of hepatitis E virus infection-permissive and -non-permissive human hepatoma PLC\/PRF\/5 subclones","volume":"59","author":"Shiota","year":"2015","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.bbrep.2018.05.007_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrep.2018.05.007_bib11","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.febslet.2015.03.022","article-title":"Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells","volume":"589","author":"Okumura","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2018.05.007_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbrc.2011.05.061","article-title":"Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents","volume":"409","author":"Ueda","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2018.05.007_bib13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/cas.12799","article-title":"Novel reporter system to monitor early stages of the hepatitis B virus life cycle","volume":"106","author":"Nishitsuji","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2018.05.007_bib14","first-page":"e54849","article-title":"Development of a hepatitis B virus reporter system to monitor the early stages of the replication cycle","volume":"120","author":"Nishitsuji","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbrep.2018.05.007_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/febs.13563","article-title":"The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly","volume":"283","author":"Dansako","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrep.2018.05.007_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2011.02.005","article-title":"Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system","volume":"157","author":"Mori","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrep.2018.05.007_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bbrep.2018.05.007_bib18","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1021\/pr3005315","article-title":"Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251","volume":"11","author":"Morita","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrep.2018.05.007_bib19","unstructured":"World Health Organization, World malaria report,\u00a02015.\u3008http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2015\/en\/\u3009."},{"key":"10.1016\/j.bbrep.2018.05.007_bib20","unstructured":"World Health Organization, Global hepatitis report, 2017.\u3008http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/\u3009."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580817302431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580817302431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T09:56:06Z","timestamp":1545040566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580817302431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"alternative-id":["S2405580817302431"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2018.05.007","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2018.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}